Mylan Pharmaceuticals

Mylan Pharmaceuticals is a global pharmaceutical company known for producing generic and specialty medications. Founded in 1961, it focuses on making medications more accessible and affordable, particularly for chronic conditions like diabetes and hypertension. Mylan gained significant attention for its EpiPen, a device used to treat severe allergic reactions. The company emphasizes research and development to innovate and improve drug therapies. In 2020, Mylan merged with Upjohn, a division of Pfizer, to form Viatris, aiming to enhance its product offerings and global reach while continuing to serve patients worldwide.